FDA approves an Ebola vaccine, long in development, for the first time – STAT
The vaccine, developed by Merck, protects against Zaire ebolaviruses, the species of the virus that has been the most common cause of Ebola outbreaks.
Related Articles
Zealand’s GLP-2 candidate shows early weight loss results
Zealand Pharma said that its obesity candidate that uses a unique mechanism led to notable weight loss in an early trial.
FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People
FDA Launches Agency-Wide AI Tool
How to keep weight off after obesity drugs
Nature – Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or availability.
How to keep weight off after obesity drugs
Nature – Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or availability.
Metsera’s amylin drug shows early potential for substantial weight loss
Metsera’s obesity drug candidate targeting the amylin hormone showed marked efficacy in an early trial, the company said
Metsera’s amylin drug shows early potential for substantial weight loss
Metsera’s obesity drug candidate targeting the amylin hormone showed marked efficacy in an early trial, the company said
Great debate: default duration of dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndrome should be 12 months
In the 1980s, atherothrombosis was definitively established as the most prevalent mechanism underlying acute coronary syndromes (ACS).1,2 In the 1990s, sin
FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People
FDA Launches Agency-Wide AI Tool
Breast Cancer Patients Get Early Warning of Faltering Drugs With Blood Test
A study found that women could switch drugs without waiting for scans showing cancer progression, which improved their quality of life.
Pew Finds BlueSky’s ‘News Influencers’ Aren’t Influencing Anyone
“Even with Bluesky’s growth, X remains popular…”